Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Dabigatran Etexilate Formulations with Pantoprazole
NCT02170636Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jan 2002
- Primary completion
- Mar 2002
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, open-label trial of dabigatran etexilate oral solution in thromboembolism, sponsored by Boehringer Ingelheim. Started Jan 2002; status: completed.
02
Drugs
dabigatran etexilate oral solution
03
Conditions
thromboembolism
Beyond the preview
Go deeper on NCT02170636.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02170636.